Engineering a Lactococcus lactis strain to produce gamma-aminobutyric acid–enriched, putrescine-free cheese
Journal of Dairy Science · 2026
DOI: 10.3168/jds.2026-28720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dairy Science, 2026. Verfasst von Lorena Sampedro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Microbiology Group, Dairy Research Institute (IPLA, CSIC), Oviedo, 33011, Spain; Molecular Microbiology Group, Instituto de Investigación S…. Hauptthemen laut MEDLINE: Lactococcus lactis, Cheese, gamma-Aminobutyric Acid, Putrescine. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigacion, Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología, CSIC.
Abstract (Originalsprache)
The neuroactive compound gamma-aminobutyric acid (GABA) is widely recognized for its potential health-promoting effects, which are driving increasing industrial interest in the development of GABA-enriched fermented foods. Microorganisms such as GABA-producing Lactococcus lactis strains are key to this approach. As the primary starter culture in the dairy industry, L. lactis is essential for the manufacture of fermented products such as cheese. Although this species is generally recognized as safe, certain strains can produce putrescine, a toxic biogenic amine whose accumulation in food products must be minimized or avoided. The main objective of this study was to delete the agmatine deiminase (AGDI) cluster-responsible for putrescine biosynthesis-in a GABA-producing L. lactis strain to obtain a variant suitable for use as a starter culture in the production of GABA-enriched, putrescine-free cheeses. The mutant was successfully generated via double homologous recombination. When cultivated in a medium supplemented with agmatine, the knockout strain did not produce putrescine; however, it retained its ability to synthesize GABA in a glutamate-supplemented medium. Furthermore, when employed as a starter culture for Cabrales-like mini cheeses, the mutant strain effectively produced cheeses with elevated GABA concentrations (ranging from 545.50 to 865.86 mg kg-1) and no detectable putrescine accumulation. Eliminating putrescine accumulation in cheese resolves the major food safety concern associated with the wild-type strain, thereby enabling its safe use as a starter culture for the production of GABA-enriched cheese, while also preventing sensory defects linked to this biogenic amine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Microbiology Group, Dairy Research Institute (IPLA, CSIC), Oviedo, 33011, Spain; Molecular Microbiology Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, 33011, S…
Förderung
- Agencia Estatal de Investigacion
- Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología
- CSIC
Zitieren
APA
Sampedro, L., Bauer, C., Redruello, B., Alvarez, M. A., & Del Rio, B. (2026). Engineering a Lactococcus lactis strain to produce gamma-aminobutyric acid–enriched, putrescine-free cheese. Journal of Dairy Science. https://doi.org/10.3168/jds.2026-28720
Vancouver
Sampedro L, Bauer C, Redruello B, Alvarez MA, Del Rio B. Engineering a Lactococcus lactis strain to produce gamma-aminobutyric acid–enriched, putrescine-free cheese. Journal of Dairy Science. 2026. doi:10.3168/jds.2026-28720
BibTeX
@article{Sampedro2026,
author = {Sampedro, Lorena and Bauer, Corina and Redruello, Begoña and Alvarez, Miguel A and Del Rio, Beatriz},
title = {Engineering a Lactococcus lactis strain to produce gamma-aminobutyric acid–enriched, putrescine-free cheese},
journal = {Journal of Dairy Science},
year = {2026},
doi = {10.3168/jds.2026-28720}
}
EUVIMED